Surviving lethal septic shock without fluid resuscitation in a rodent model

Surgery

Volumn 148, Issue 2, 2010, Pages 246-254

  Li, Yongqing ^a   Liu, Baoling ^a   Fukudome, Eugene Y ^a   Kochanek, Ashley R ^a   Finkelstein, Robert A ^a,b   Chong, Wei ^a   Jin, Guang ^a   Lu, Jennifer ^a   Demoya, Marc A ^a   Velmahos, George C ^a   Alam, Hasan B ^a  

^a Division of Trauma   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; TUMOR NECROSIS FACTOR ALPHA; VORINOSTAT; AUTACOID; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; MYD88 PROTEIN, MOUSE; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DISEASE MODEL; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; LETHAL DOSE; LUNG PARENCHYMA; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SURVIVAL TIME; TREATMENT OUTCOME; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; CHEMICALLY INDUCED DISORDER; FLUID THERAPY; GENETICS; LUNG; METABOLISM; NUCLEOTIDE SEQUENCE; RESUSCITATION;

ANIMALS; BASE SEQUENCE; CELL LINE; DISEASE MODELS, ANIMAL; DNA PRIMERS; FLUID THERAPY; GENE EXPRESSION; HISTONE DEACETYLASE INHIBITORS; HYDROXAMIC ACIDS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MYELOID DIFFERENTIATION FACTOR 88; RESUSCITATION; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955287968     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2010.05.003     Document Type: Article

References (28)

1. H. Weighardt, and B. Holzmann Role of toll-like receptor responses for sepsis pathogenesis Immunobiology 212 2008 715 722
2. P. Gallinari, S. Di Marco, P. Jones, M. Pallaoro, and C. Steinkuhler HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics Cell Res 17 2007 195 221
3. M. Dokmanovic, C. Clarke, and P.A. Marks Histone deacetylase inhibitors: overview and perspectives Mol Cancer Res 5 2007 981 989 (Pubitemid 350080267)
4. X.L. Yang, and E. Seto Lysine acetylation: codified crosstalk with other posttranslational modifications Mol Cell 31 2008 449 461
5. M.A. Halili, M.R. Andrews, M.J. Sweet, and D.P. Fairlie Histone deacetylase inhibitor in inflammatory disease Curr Top Med Chem 9 2009 309 319
6. Y. Li, B. Liu, H. Zhao, E.A. Saihamer, E.Y. Fukudome, and X. Zhang Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents Shock 32 2009 517 523
7. S. Janssens, and R. Beyaert A universal role for MyD88 in TLR/IL-1R-mediated signaling Trends Biochem Sci 27 2002 474 482
8. T. Kawai, O. Adachi, T. Ogawa, K. Takeda, and S. Akira Unresponsiveness of MyD88-deficient mice to endotoxin Immunity 11 1999 115 122
9. B. Beutler Tlr4: central component of sole mammalian LPS sensor Curr Opin Immunol 12 2000 20 26
10. J.E. Bolden, M.J. Peart, and R.W. Johnstone Anticancer activities of histone deacetylase inhibitors Nat Rev Drug Discov 5 2006 769 784
11. A.G. Kazantsev, and L.M. Thompson Therapeutic application of histone deacetylase inhibitors for central nervous system disorders Nat Rev Drug Discov 7 2008 854 868
12. T. Lin, H. Chen, E. Koustova, E.A. Sailhamer, Y. Li, and C. Shults Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver Surgery 141 2007 784 794
13. H.B. Alam, C. Shults, N. Ahuja, E.C. Ayuste, H. Chen, and E. Koustova Impact of resuscitation strategies on the acetylation status of cardiac histones in a swine model of hemorrhage Resuscitation 76 2008 299 310
14. E. Gonzales, H. Chen, R. Munuve, T. Mehrani, J. Britten-Webb, and A. Nadel Valproic acid prevents hemorrhage-associated lethality and affects the acetylation pattern of cardiac histones Shock 25 2006 395 401
15. E.A. Sailhamer, Y. Li, E.J. Smith, F. Shuja, C. Shults, and B. Liu Acetylation: a novel method for modulation of the immune response following trauma/hemorrhage and inflammatory second hit in animals and humans Surgery 144 2008 204 216
16. Y.C. Lu, W.C. Yeh, and P.S. Ohashi LPS/TLR4 signaling transduction pathway Cytokine 42 2008 145 151
17. G.J. Brunn, M.K. Bungum, G.B. Johnson, and J.L. Platt Conditional signaling by Toll-like receptor 4 FASEB J 19 2005 872 874
18. G. Brunn, and J. Platt The etiology of sepsis: turned inside out Trends Mol Med 12 2006 10 16
19. G.M. Campo, A. Avenoso, S. Campo, P. Traina, A. D'Ascola, and A. Calatroni Glycosaminoglycans reduced inflammatory response by modulating toll-like receptor-4 in LPS-stimulated chondrocytes Arch Biochem Biophys 491 2009 7 15
20. H. Shen, and A.B. Lentsch Progressive dysregulation of transcription factors NF-κB and STAT1 in prostate cancer cells causes proangiogenic production of CXC chemokines Am J Physiol Cell Physiol 286 2004 C840 C847
21. A. Kimura, T. Naka, T. Nakahama, K. Masuda, K. Nohara, and Y. Fujii-Kuriyama Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses J Exp Med 206 2009 2027 2035
22. O.H. Kramer, D. Baus, S.K. Knauer, S. Stein, E. Jager, and R.H. Stauber Acetylation of Stat1 modulates NF-κB activity Genes Dev 20 2006 473 485
23. M. Buchwald, O.H. Kramer, and T. Heinzel HDACi: targets beyond chromatin Cancer Letters 280 2009 160 167
24. K.R. Wasiluk, K.A. McCuloch, K.L. Banton, and D.L. Dunn NF-κB elements regulate transcriptional activity within the murine MyD88 promoter J Surg Res 130 2006 332
25. M.A. Glozak, N. Sengupta, X. Zhang, and E. Seto Acetylation and deacetylation of non-histone proteins Gene 363 2005 15 23
26. G. Liu, Y.J. Park, Y. Tsuruta, E. Lorne, and E. Abraham p53 attenuates lipopolysaccharide-induced NF-κB activation and acute lung injury J Immunol 182 2009 5063 5071
27. R. Glauben, A. Batra, I. Fedke, M. Zeitz, H.A. Lehr, and F. Leoni Histone hyperacetylation is associated with amelioration of experimental colitis in mice J Immunol 176 2006 5015 5022
28. H.S. Lin, C.Y. Hu, H.Y. Chan, Y.Y. Liew, H.P. Huang, and L. Lepescheux Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents B J Pharmacol 150 2007 862 872